All Articles
-
European Summit for Cardiovascular Diseases Prevention
"Bridging the unacceptable gap between what is recommended and what is achieved in daily practice regarding the prevention of cardiovascular disease" is how Prof Guy De Backer, Chairman of the CVD Prevention Committee of the European Society of Cardiology (ESC), summarises the aim of the European Summit on Cardiovascular Disease Prevention. Creating...
READ MORE -
Mechanical Circulatory Support:New Generation Devices Mark a New Era
Long-term Mechanical Circulatory Support (MCS) was initially used in clinical practice to bridge patients in end-stage heart failure through to heart transplantation. Rapid developments have, however, led to the use of newer generation devices that promise to minimise the morbidity and mortality associated with their use and to improve the quality...
READ MORE -
Evaluating Heart Diseases: The Role of Cardiac Imaging
Coronary artery disease (CAD) is the leading cause of mortality in the industrial world. Cardiac imaging is essential to establish the diagnosis and severity of CAD and to determine the potential risk of future cardiovascular events. In patients with suspected CAD, evaluation of patient history will reveal the presence of cardiac risk factors and...
READ MORE -
Interview with Prof.Stefanadis
Please Tell Us About Your Background in the Field of Cardiology. I graduated from the University of Athens Medical School in 1971 and during my undergraduate studies, I had the chance to attend subspecialty rotations, during which I was captivated by exciting advances in the field of cardiology. I was particularly inspired by the development...
READ MORE -
EU News: Seventh Framework Programme for Research and Technological Development
Author: Dervla Gleeson Managing Editor The Seventh Framework Programme for Research and Technological Development (FP7) is the European Union's (EU) main instrument for funding research in Europe. Running from 2007 to 2013, it will execute a budget during that period of €50.5 billion and an additional Euratom budget for the next five...
READ MORE -
World,Research,Industry
World World Health Organization Reports Highest Rates Of Drug- Resistant Tuberculosis To Date www.who.int Multidrug-resistant tuberculosis (MDR-TB) has been recorded at the highest rates ever, according to a new World Health Organization (WHO) report that presents findings from the largest survey to date on the scale of...
READ MORE -
Industry News
US FDA Advises Caution on Baxter's Multiple-Dose Vial Heparin Baxter Healthcare Corporation has temporarily stopped manufacturing multiple-dose vials of the injectable blood-thinning drug heparin due to reports of serious allergic reactions and hypotension in patients who receive high bolus doses of the drug. Adverse events have not been...
READ MORE -
Current Controversies in Ventilator-Associated Pneumonia
Part 1: Epidemiology and Pathophisiology Authors Karen E Pickett MB, BCh Medical Writer/Editor Department of Intensive Care Erasmus Hospital Brussels, Belgium Ventilator-associated pneumonia (VAP) is a common complication in mechanically ventilated patients and is associated with a considerable increase...
READ MORE -
Critical Care in Brazil
News Safe Hospitals, A Global Strategy In the framework of the Global Platform for Disaster Risk Reduction meeting, held in Geneva, WHO and PAHO organised a workshop on disaster risk reduction in health facilities and the health sector to call attention to the serious effects that emergencies, disasters and other crises have on health...
READ MORE -
Data Management System
ECRI Institute is a totally independent nonprofit research agency designated as a Collaborating Center of the World Health Organization (WHO). Such organizations are appointed to contribute to WHO’s public health mission by providing specialized knowledge, expertise, and support in the health field to the WHO and its member nations. ECRI Institute...
READ MORE
INFO
IMAGING
ICU
EXEC
IT
CARDIOLOGY
JOURNALS
EVENTS
FACULTY
PARTNERS
BLOG
VIDEOS
CONTACT US
